Table 1.
Demographic/clinical data of study individuals.
| Study individual | OT1 | OT2 | OT3 | OT4 | OT5 | CR Group (n = 13) | Sta group (n = 19) | HI group (n = 11) |
|---|---|---|---|---|---|---|---|---|
| Age (years) | 53 | 42 | 43 | 49 | 32 | 44 (27–64) | 50 (25–78) | 41 (30–57) |
| Sex (F, M) | M | M | F | F | M | 4, 9 | 10, 9 | 6, 5 |
| Number of grafts | 1 | 2 | 1 | 1 | 1 | 1 (n = 13) 2 (n = 1) |
1 (n = 18) | NA |
| Time of transplantation (years) | 23 | 5 | 7 | 23 | 13 | 8 (4–13) | 8 (1–34) | NA |
| Induction therapy | NA | Anti-CD25 | No | No | No | 5 of 13 Anti-CD25 = 4 ATG = 1 |
14 of 19 Anti-CD25 = 13 ATG + IVIG = 1 |
NA |
| HLA (A, B, DR) mismatches | 3 | 4 | 0 | 0 | 3 | 4.45 ± 1.75 (n = 11) NA (n = 2) |
3.83 ± 1.30 (n = 18) NA (n = 1) |
NA |
| Donor (living, deceased) | Living | Deceased | Living | Living | Living | 6, 7 | 16, 3 | NA |
| Blood transfusion (Y, N) | NA | Y | N | Y | N | 6, 3 NA (n = 4) |
11, 3 NA (n = 5) |
NA |
| Acute rejection episode (Y, N) | N | Y | N | N | N | 8, 5 | 6, 13 | NA |
| Viral infections (Y, N) | NA | Y | NA | N | N | 7, 5 | 4, 15 | NA |
| Reason for immunosuppression interruption | Non-compliance | Non-compliance | Non-compliance | Non-compliance | Non-compliance | NA | NA | NA |
| Drug-free time (years) | 6 | 1.5 | 4.1 | 8 | 4 | NA | NA | NA |
ATG, antithymocyte globulin; NA, not available or does not apply; IVIG, intravenous immunoglobulin. The numeric data are represented as mean ± standard deviation. Age (years): the age range for each group is shown in the parentheses. Time of transplantation: the time range is shown in the parentheses.